# China Substance Abuse Treatment Market

> China Substance Abuse Treatment Market Research Report By Type (Alcohol Dependence, Tobacco & Drug Abuse) and By End User (Outpatient Treatment Centers, Residential Treatment Centers, Inpatient Treatment Centers) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 12.51%
- **2024:** $ 682.5 Million
- **2025:** $ 767.88 Million
- **2035:** $ 2,496 Million
- **Key Players:** Acadia Healthcare (US), American Addiction Centers (US), Caron Treatment Centers (US), Hazelden Betty Ford Foundation (US), Lifeworks (GB), Prominence Treatment Center (US), Recovery Centers of America (US), Sierra Tucson (US)

**Report ID:** MRFR/HC/48618-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/china-substance-abuse-treatment-market-50375

---

## Market Summary

## **China Substance Abuse Treatment Market Overview**

As per MRFR analysis, the China Substance Abuse Treatment Market Size was estimated at 486 (USD Million) in 2023.The China Substance Abuse Treatment Market Industry is expected to grow from 546(USD Million) in 2024 to 1,860 (USD Million) by 2035. The China Substance Abuse Treatment Market CAGR (growth rate) is expected to be around 11.787% during the forecast period (2025 - 2035).

**Key China Substance Abuse Treatment Market Trends Highlighted**

Rising awareness and changing views about drug misuse are driving many significant developments in the China Substance Abuse Treatment Market. Rising drug addiction among young people, especially in relation to synthetic narcotics and opioids, has led the Chinese government to adopt many measures meant to fight substance misuse. Rising initiatives, including improved public health campaigns and educational programs, are helping to propel demand for more thorough treatment choices.

The government's emphasis on enhancing mental health services has also opened the door for integrated treatment strategies combining mental health support with drug misuse care, so serving a more general spectrum of requirements for those looking for assistance.

Especially in the area of technological integration, possibilities in this sector are ripe for the grabbing. Especially in remote locations where access to conventional treatment centres may be restricted, the growth of telemedicine and Internet counselling services provides a fresh path for addressing drug dependence. Furthermore, more people are choosing holistic and individualized treatment programs that go beyond traditional approaches, suggesting a market shift towards alternative treatments and support groups. Lately, cooperation between government organizations and private hospitals to improve the general efficacy of treatment programs has been very obvious.

Community-based projects are also becoming more popular since they emphasize rehabilitation and reintegration of recovered addicts into society. These initiatives underline a movement towards a more inclusive attitude towards drug misuse, seeking to reduce stigma and foster acceptance. For those wanting to grasp the dynamics of the China Substance Abuse Treatment Market, these trends and changes are especially important as the market evolves.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**China Substance Abuse Treatment Market Drivers**

**Increasing Substance Abuse Cases in China**

The prevalence of substance abuse in China has risen dramatically in recent years, especially with the increase in the consumption of opioids and synthetic drugs. According to the National Narcotics Control Commission of China, the number of registered drug users in China reached over 2.5 million in 2020, marking a substantial increase compared to previous years. This alarming trend drives the demand for effective substance abuse treatment solutions.

With governmental entities like the Narcotics Control Bureau increasing funding for rehabilitation programs, there is a significant market opportunity emerging in the China Substance Abuse Treatment Market Industry. By focusing on policies aimed at reducing drug-related crimes and increasing availability of treatment, authorities are contributing to a market poised for growth, reflecting a holistic approach towards tackling addiction within the community.

**Government Initiatives and Support Programs**

The Chinese government has implemented various initiatives to combat substance abuse, such as the '13th Five-Year Plan' which emphasizes the importance of drug rehabilitation and prevention. Such policies not only provide funding for treatment facilities but also raise awareness about the dangers of drug abuse. 

The establishment of specialized treatment centers backed by organizations such as the Ministry of Health serves to create a solid foundation for growth in the China Substance Abuse Treatment Market Industry.Moreover, local governments are encouraged to integrate substance abuse treatment into public health initiatives, which systematically supports the increasing demand for comprehensive treatment services.

**Rising Mental Health Awareness**

As mental health awareness grows in China, the stigma associated with substance abuse is gradually diminishing. According to findings from the China Health and Nutrition Survey, roughly 16% of the population showed signs of mental disorders, which correlates with substance abuse cases. This growing acknowledgment of mental health issues encourages individuals to seek treatment, thereby expanding the market for substance abuse treatment facilities and services.

Organizations such as the Chinese Mental Health Association are actively promoting public awareness campaigns, leading to a significant increase in the number of people seeking assistance for substance use disorders. This change in societal perception is vital for the expansion of the China Substance Abuse Treatment Market Industry.

**China Substance Abuse Treatment Market Segment Insights**

**Substance Abuse Treatment Market Type Insights**

The China Substance Abuse Treatment Market is experiencing significant developments, driven by rising awareness and increasing cases of substance dependence among the population. Within this market, the Type segment encompasses various areas of treatment including Alcohol Dependence, Tobacco, and Drug Abuse. Alcohol Dependence is particularly significant as it poses severe health risks and societal implications, prompting a series of treatment programs aimed at reducing consumption and promoting recovery. Tobacco usage in China remains a critical concern, triggering comprehensive public health initiatives focused on cessation strategies and support systems for individuals striving to quit.

Furthermore, Drug Abuse encompasses a variety of illicit substances, leading to tailored treatment solutions that address both physical and psychological dependencies. The growing rate of drug-related issues has accentuated the need for dedicated therapeutic measures, making this segment pivotal in shaping effective intervention strategies. Addressing these issues requires a multifaceted approach, incorporating behavioral therapies, medications, and community support to foster long-lasting recovery outcomes for individuals in China. 

As the government continues to prioritize substance abuse treatment through policy reforms and increased funding, the market is set for continued growth and evolution, providing vital resources for those affected by substance use disorders.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Substance Abuse Treatment Market End User Insights**

The End User segment of the China Substance Abuse Treatment Market encompasses various facilities that play a critical role in addressing substance addiction, including Outpatient Treatment Centers, Residential Treatment Centers, and Inpatient Treatment Centers. Outpatient Treatment Centers offer flexibility, allowing patients to maintain their daily commitments while receiving support, which is vital in urbanized areas of China where commuting is common. On the other hand, Residential Treatment Centers provide a more immersive experience, usually preferred for severe cases, as they facilitate around-the-clock supervision and access to therapeutic programs.Inpatient Treatment 

Centers are crucial for patients requiring medical detoxification and urgent intervention, helping to stabilize their condition in a controlled environment. As the prevalence of substance abuse continues to grow in China, these facilities are becoming increasingly significant in the overall treatment landscape. Moreover, China's government initiatives aimed at combating substance addiction have further spurred the development of these centers, reflecting a societal recognition of the importance of specialized treatment options.The market dynamics suggest that these centers are not only vital in treating addiction but also in providing preventative measures to curb the rising trend of substance abuse.

**China Substance Abuse Treatment Market Key Players and Competitive Insights**

The China Substance Abuse Treatment Market is experiencing a notable evolution driven by increasing awareness of substance abuse issues and the growing burden of addiction on public health. As the market expands, competition intensifies among various players, including pharmaceutical companies, rehabilitation centers, and healthcare providers. The rising prevalence of substance abuse disorders in China necessitates innovative treatment options and holistic care approaches. The competitive landscape is further influenced by regulatory policies, the integration of technology in treatment solutions, and partnerships between public and private sectors aimed at improving treatment accessibility and efficacy.

As a result, market participants are compelled to enhance their offerings, address patient needs, and differentiate themselves in a rapidly changing environment.

Qingdao Huanghai Pharmaceutical has established itself as a significant player in the China Substance Abuse Treatment Market through its commitment to developing high-quality pharmaceutical products. The company leverages its strong R&D capabilities to innovate and provide effective treatment options for substance abuse disorders. With a robust distribution network across China, Qingdao Huanghai Pharmaceutical ensures that its products reach a broad customer base, facilitating timely intervention and care for individuals struggling with addiction.

The company’s well-established presence in the market is bolstered by strategic collaborations and partnerships, enhancing its ability to adapt to evolving consumer demands and regulatory requirements, positioning itself favorably within the competitive landscape.

Shanghai Mental Health Center plays a vital role in the China Substance Abuse Treatment Market by offering comprehensive mental health services, including specialized treatments for substance abuse. This institution is recognized for its evidence-based approaches and cutting-edge therapeutic practices, providing a range of services such as counseling, rehabilitation programs, and educational resources. By fostering partnerships with various healthcare providers and institutions, Shanghai Mental Health Center enhances its market presence, ensuring a collaborative approach to addiction treatment. 

The center's emphasis on research and innovation enables it to remain at the forefront of mental health and substance abuse treatment in China. Additionally, ongoing investments in training and development for healthcare professionals further strengthen its service quality, making it a reputable choice for individuals seeking support in managing substance abuse issues.

**Key Companies in the China Substance Abuse Treatment Market Include:**

- Qingdao Huanghai Pharmaceutical
- Shanghai Mental Health Center
- Shenzhen Hanhai Pharmaceutical
- Zhejiang Huadong Medicine
- Nanjing Baiyu Pharmaceutical
- Jiangsu Chiatai Qingjian Pharmaceutical
- Hunan Yanshan Pharmaceutical
- Guangdong Saiqi Pharmaceutical
- Shenzhen Xisen Pharmaceutical
- Tianjin Jinxi Pharmaceutical
- Shanghai Zhangjiang Pharmaceutical
- Sichuan New Huadu Pharmaceutical
- Xi'an Yufeng Pharmaceutical
- Beijing Tiantan Hospital
- Zhongshan Zhenye Pharmaceutical

**China Substance Abuse Treatment Market Industry Developments**

The China Substance Abuse Treatment Market has witnessed significant developments recently, marked by an increasing focus on innovative treatment methods and growing governmental support for addiction recovery initiatives. Companies such as Qingdao Huanghai Pharmaceutical, Shanghai Mental Health Center, and Shenzhen Hanhai Pharmaceutical are making strides in Research and Development efforts to enhance therapeutic options. 

Current affairs in the market reveal ongoing initiatives aimed at expanding facilities and improving accessibility to treatment programs, addressing the rising cases of substance abuse in urban areas. Notably, in March 2023, Zhejiang Huadong Medicine announced a strategic partnership with local health authorities to advance outreach programs that offer mental health support alongside substance abuse treatment. Meanwhile, in July 2022, Jiangsu Chiatai Qingjian Pharmaceutical acquired a minority stake in a new rehabilitation center in Hunan province, further enhancing its service offerings. 

The market has seen substantial growth, driven by increasing awareness of mental health issues and the urgent need for effective intervention strategies. Such developments contribute to shaping a more robust framework for combating substance addiction across China, while companies like Guangdong Saiqi Pharmaceutical and Tianjin Jinxi Pharmaceutical are increasing their market presence through innovative products and services tailored to address specific community needs.

**China Substance Abuse Treatment Market Segmentation Insights**

**Substance Abuse Treatment Market Type Outlook**

- Alcohol Dependence
- Tobacco & Drug Abuse

**Substance Abuse Treatment Market End User Outlook**

- Outpatient Treatment Centers
- Residential Treatment Centers
- Inpatient Treatment Centers

## Market Drivers

### Government Policy Reforms

Recent government policy reforms aimed at combating substance abuse are significantly impacting the substance abuse-treatment market. The Chinese government has implemented various initiatives to strengthen the legal framework surrounding drug use and treatment. These reforms include increased funding for treatment programs and the establishment of stricter regulations on substance distribution. As a result, the market is witnessing a shift towards more structured and regulated treatment options. The government has also launched campaigns to promote awareness and prevention, which are likely to lead to an increase in individuals seeking treatment. With these policy changes, the substance abuse-treatment market is expected to experience growth as it aligns with national health objectives and priorities.

### Emergence of Telehealth Services

The emergence of telehealth services is transforming the substance abuse-treatment market in China. With advancements in technology, remote treatment options are becoming increasingly popular, particularly for individuals who may face barriers to accessing traditional in-person services. Telehealth allows for greater flexibility and convenience, enabling patients to receive care from the comfort of their homes. Recent data suggests that telehealth utilization for substance abuse treatment has increased by approximately 20% in the past year. This trend is likely to continue as more individuals recognize the benefits of virtual consultations and support groups. The integration of telehealth into the substance abuse-treatment market is expected to enhance accessibility and engagement, ultimately leading to improved treatment outcomes.

### Increased Focus on Mental Health

The growing recognition of the link between mental health and substance abuse is influencing the substance abuse-treatment market. Mental health issues often co-occur with substance use disorders, and addressing both simultaneously is becoming a priority in treatment approaches. Recent studies indicate that nearly 30% of individuals with substance use disorders also experience mental health conditions. This understanding has led to the development of integrated treatment programs that cater to both aspects, thereby enhancing recovery outcomes. As mental health awareness continues to rise in China, the demand for comprehensive treatment solutions is likely to increase, further propelling the substance abuse-treatment market. The integration of mental health services into substance abuse treatment is expected to create a more holistic approach, ultimately benefiting individuals seeking help.

### Expansion of Rehabilitation Facilities

The expansion of rehabilitation facilities across China is a crucial driver for the substance abuse-treatment market. In recent years, there has been a notable increase in the number of treatment centers, with estimates suggesting a growth rate of around 15% annually. This expansion is largely due to the rising demand for accessible treatment options, as more individuals seek help for substance abuse disorders. Additionally, the government has been supportive of this growth, providing funding and resources to establish new facilities. The availability of diverse treatment programs, including inpatient and outpatient services, is likely to cater to a wider range of needs, thus enhancing the overall effectiveness of the substance abuse-treatment market. As these facilities continue to proliferate, they will play a pivotal role in addressing the growing substance abuse crisis in the country.

### Rising Awareness of Substance Abuse Issues

The increasing awareness of substance abuse issues in China is driving the substance abuse-treatment market. Public campaigns and educational programs have highlighted the dangers of addiction, leading to a greater demand for treatment services. According to recent statistics, approximately 9.5% of the population has reported substance use disorders, which has prompted both governmental and non-governmental organizations to take action. This heightened awareness is likely to result in more individuals seeking help, thereby expanding the market. Furthermore, the stigma surrounding addiction is gradually diminishing, encouraging more people to pursue treatment options. As a result, the substance abuse-treatment market is expected to grow as more individuals recognize the importance of addressing their addiction issues and accessing available resources.

## Future Outlook

The [Substance Abuse Treatment Market](https://www.marketresearchfuture.com/reports/substance-abuse-treatment-market-7230) in China is projected to grow at a 12.51% CAGR from 2025 to 2035, driven by increasing awareness and government initiatives.

**New opportunities:**

- Expansion of telehealth services for remote patient monitoring.
- Development of personalized treatment plans using AI analytics.
- Investment in community-based rehabilitation programs to enhance accessibility.

By 2035, the market is expected to achieve substantial growth, reflecting evolving treatment paradigms and increased investment.

## Segment Insights

### By Type: Alcohol Dependence (Largest) vs. Tobacco & Drug Abuse (Fastest-Growing)

In the China substance abuse-treatment market, Alcohol Dependence represents the largest segment, capturing a significant market share due to cultural factors and a deeply rooted history of alcohol consumption. Tobacco & Drug Abuse follows, reflecting changing socio-economic dynamics and increasing awareness about the health impacts of substances. This distribution indicates shifting priorities within treatment modalities, with an emphasis on developing robust programs tailored for alcohol dependence and addressing the rise in drug abuse cases.

Growth trends indicate a rising prevalence of both segment values, driven largely by urbanization, changing lifestyles, and increased stressors in modern society. The landscape is evolving as policy initiatives target stricter regulations on tobacco and drug use, coupled with enhanced public health campaigns. Consequently, Alcohol Dependence remains a focal point of treatment efforts, while Tobacco & Drug Abuse is emerging rapidly, supported by growing demand for effective intervention strategies.

Alcohol Dependence: Dominant vs. Tobacco & Drug Abuse: Emerging

Alcohol Dependence is the dominant segment in the China substance abuse-treatment market, characterized by long-standing societal acceptance coupled with a high prevalence rate. Treatment options range from outpatient counseling to inpatient rehabilitation programs, tailored to meet diverse needs. Meanwhile, Tobacco & Drug Abuse is emerging as a significant concern, with rising incidents prompting the need for specialized treatment strategies. Innovative therapies and holistic approaches are gaining traction, as practitioners seek effective methods to address both tobacco and drug dependencies. The proactive shift in public perception and health policies is anticipated to further boost the growth of this segment, highlighting the increasing importance of comprehensive treatment frameworks.

### By End User: Outpatient Treatment Centers (Largest) vs. Residential Treatment Centers (Fastest-Growing)

In the China substance abuse-treatment market, outpatient treatment centers account for the largest share among the end user segment, reflecting the increasing preference for flexible treatment solutions. These centers provide various services that cater to patients' needs while allowing them to maintain their daily routines. Residential treatment centers, on the other hand, show tremendous growth potential, driven by the rising awareness of the importance of structured rehabilitation environments, capturing a growing segment of the population seeking dedicated care for substance abuse issues.

The growth trends in this segment highlight the shift towards more accessible treatment options and the need for comprehensive care approaches. Factors such as increased funding from government initiatives and higher investment from private sectors are fueling advancements in outpatient models. Moreover, the surge in substance abuse cases has led to a bolstered demand for effective treatment solutions, further propelling the fastest-growing categories like residential treatment facilities, which are seen as critical in providing intensive therapeutic support for individuals in need.

Outpatient Treatment Centers: Dominant vs. Residential Treatment Centers: Emerging

Outpatient treatment centers in the China substance abuse-treatment market serve as the dominant force, largely owing to their flexible nature and broad reach, allowing individuals to receive care while continuing with their daily lives. These facilities typically offer counseling, support groups, and medication management that cater to a wide array of substance abuse issues. Conversely, residential treatment centers are emerging as a crucial component of the treatment landscape, providing immersive and structured environments for individuals with severe addiction challenges. These centers often emphasize personalized recovery plans and 24/7 care, which are essential for fostering long-term recovery. As public awareness increases regarding the efficacy of residential treatment, these facilities are anticipated to grow rapidly, establishing themselves as vital options for comprehensive substance abuse recovery.

## Competitive Benchmarking

The substance abuse-treatment market in China is characterized by a complex competitive landscape, driven by increasing awareness of mental health issues and a growing demand for effective treatment solutions. Key players are actively positioning themselves through various strategies, including regional expansion, digital transformation, and partnerships. Companies such as Acadia Healthcare (US) and American Addiction Centers (US) are focusing on enhancing their service offerings and expanding their geographical reach, which collectively shapes a competitive environment that is both dynamic and evolving.In terms of business tactics, companies are increasingly localizing their services to better cater to the unique cultural and social contexts of their clients. This localization, coupled with supply chain optimization, is essential in a market that appears moderately fragmented. The influence of major players is significant, as they not only set industry standards but also drive innovation through their operational strategies.

In October  Acadia Healthcare (US) announced a strategic partnership with a local Chinese healthcare provider to enhance its service delivery in the region. This collaboration is expected to leverage local expertise and improve access to treatment for individuals struggling with substance abuse, thereby reinforcing Acadia's commitment to expanding its footprint in the Chinese market. The strategic importance of this partnership lies in its potential to enhance patient outcomes through culturally sensitive care.

In September  American Addiction Centers (US) launched a new telehealth platform aimed at providing remote support for individuals in recovery. This initiative reflects a growing trend towards digitalization in the treatment sector, allowing for greater accessibility and flexibility in care. The strategic significance of this move is underscored by the increasing demand for remote treatment options, particularly in a post-pandemic landscape where convenience and accessibility are paramount.

In August  Hazelden Betty Ford Foundation (US) expanded its treatment offerings by integrating holistic therapies into its programs. This strategic shift towards a more comprehensive approach to treatment is indicative of a broader trend within the industry, where there is a growing recognition of the importance of addressing the psychological and emotional aspects of recovery. The integration of holistic therapies may enhance patient engagement and improve overall treatment efficacy.

As of November  current competitive trends in the substance abuse-treatment market include a pronounced focus on digitalization, sustainability, and the integration of artificial intelligence (AI) in treatment protocols. Strategic alliances are increasingly shaping the landscape, as companies recognize the value of collaboration in enhancing service delivery and operational efficiency. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition towards a focus on innovation, technology, and the reliability of supply chains. This shift suggests that companies that prioritize these elements will be better positioned to thrive in an increasingly competitive environment.

## Recent News & Developments

The China Substance Abuse Treatment Market has witnessed significant developments recently, marked by an increasing focus on innovative treatment methods and growing governmental support for addiction recovery initiatives. Companies such as Qingdao Huanghai Pharmaceutical, Shanghai Mental Health Center, and Shenzhen Hanhai Pharmaceutical are making strides in Research and Development efforts to enhance therapeutic options. 

Current affairs in the market reveal ongoing initiatives aimed at expanding facilities and improving accessibility to treatment programs, addressing the rising cases of substance abuse in urban areas. Notably, in March 2023, Zhejiang Huadong Medicine announced a strategic partnership with local health authorities to advance outreach programs that offer mental health support alongside substance abuse treatment. Meanwhile, in July 2022, Jiangsu Chiatai Qingjian Pharmaceutical acquired a minority stake in a new rehabilitation center in Hunan province, further enhancing its service offerings. 

The market has seen substantial growth, driven by increasing awareness of mental health issues and the urgent need for effective intervention strategies. Such developments contribute to shaping a more robust framework for combating substance addiction across China, while companies like Guangdong Saiqi Pharmaceutical and Tianjin Jinxi Pharmaceutical are increasing their market presence through innovative products and services tailored to address specific community needs.

## Report Scope

| MARKET SIZE 2024 | 682.5(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 767.88(USD Million) |
| MARKET SIZE 2035 | 2496.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 12.51% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Acadia Healthcare (US), American Addiction Centers (US), Caron Treatment Centers (US), Hazelden Betty Ford Foundation (US), Lifeworks (GB), Prominence Treatment Center (US), Recovery Centers of America (US), Sierra Tucson (US) |
| Segments Covered | Type, End User |
| Key Market Opportunities | Integration of digital therapeutics and telehealth solutions in the substance abuse-treatment market. |
| Key Market Dynamics | Rising demand for personalized treatment approaches in substance abuse-treatment market driven by evolving consumer preferences and regulatory support. |
| Countries Covered | China |

## Frequently Asked Questions

**Q: What was the market valuation of the China substance abuse-treatment market in 2024?**
A: The market valuation was $682.5 Million in 2024.

**Q: What is the projected market valuation for the China substance abuse-treatment market by 2035?**
A: The projected valuation for 2035 is $2496.0 Million.

**Q: What is the expected CAGR for the China substance abuse-treatment market during the forecast period 2025 - 2035?**
A: The expected CAGR is 12.51% during the forecast period 2025 - 2035.

**Q: Which segments are included in the China substance abuse-treatment market?**
A: The segments include Alcohol Dependence and Tobacco & Drug Abuse.

**Q: What were the revenue ranges for Alcohol Dependence in the China substance abuse-treatment market?**
A: The revenue range for Alcohol Dependence was $300.0 Million to $1100.0 Million.

**Q: What were the revenue ranges for Tobacco & Drug Abuse in the China substance abuse-treatment market?**
A: The revenue range for Tobacco & Drug Abuse was $382.5 Million to $1396.0 Million.

**Q: What types of treatment centers are included in the end-user segment of the market?**
A: The end-user segment includes Outpatient Treatment Centers, Residential Treatment Centers, and Inpatient Treatment Centers.

**Q: What were the revenue ranges for Outpatient Treatment Centers in the China substance abuse-treatment market?**
A: The revenue range for Outpatient Treatment Centers was $136.5 Million to $511.0 Million.

**Q: What were the revenue ranges for Residential Treatment Centers in the China substance abuse-treatment market?**
A: The revenue range for Residential Treatment Centers was $204.0 Million to $765.0 Million.

**Q: What were the revenue ranges for Inpatient Treatment Centers in the China substance abuse-treatment market?**
A: The revenue range for Inpatient Treatment Centers was $342.0 Million to $1220.0 Million.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/china-substance-abuse-treatment-market-50375*